Developer docs
API playgroundTry for free, no card

Search company profiles

Infusion Associates

Full company profile

uuid000crwg

Namestring
Infusion Associates
Legal namestring
Infusion Associates
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Infusion Associates is an ambulatory infusion services provider headquartered in Grand Rapids, Michigan, that operates outpatient clinical sites delivering intravenous therapies prescribed by physicians for patients with chronic conditions, autoimmune disorders, and other illnesses requiring regular IV administration. The company runs a network of 14 physical infusion centers across Michigan, Minnesota, Ohio, and Wisconsin, positioning itself as a lower-cost, more convenient site of care relative to hospital-based infusion settings. Its value proposition emphasizes community-based access, flexible scheduling including weekends, and in-network status with major commercial payers and government programs (Medicare, Medicare Advantage, Medicaid), reducing patient out-of-pocket cost and supporting referral conversion.

The business operates on a managed-services revenue model, billing through medical codes against insurance reimbursement and patient payments rather than disclosed consumer pricing. Its go-to-market is sales-led and referral-driven: physician practices and healthcare providers are the primary demand channel, with a streamlined referral process, transparent communication back to referring clinicians, and broad payer in-network status serving as the principal commercial assets. Under private equity owner Boyne Capital, the company grew from a single Michigan site to 14 Midwest locations, demonstrating a replicable multi-site expansion playbook. On July 9, 2024, Boyne Capital sold Infusion Associates to Vivo Infusion, which is backed by InTandem Capital Partners and raised nearly $150 million in additional equity during 2024 to continue the roll-up strategy; following the transaction, Infusion Associates operates as part of Vivo's network of approximately 80 ambulatory infusion centers across 15 states. Core technology, proprietary platforms, and AI/ML capabilities are not disclosed in available sources.

Short descriptiontext

Infusion Associates operates a network of 14 ambulatory infusion centers across Michigan, Minnesota, Ohio, and Wisconsin, providing outpatient IV therapies to chronic disease patients referred by their physicians. The PE-backed company was acquired by Vivo Infusion in July 2024.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGrand Rapids, United States
HQ citystring
Grand Rapids
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ambulatory infusion services, outpatient infusion therapy, chronic disease infusion, IV therapy clinics, infusion care centers
Industry2 codes
PRIMARYHLAFABAF
Infusion Therapy Centers (Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code3 codes
  • Outpatient Care Centers6214
  • All Other Outpatient Care Centers621498
  • Other Outpatient Care Centers62149
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Ambulatory Infusion Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Ambulatory Infusion Services
TypeManaged Services
Description

Healthcare services revenue generated from providing infusion therapy treatments to patients at ambulatory infusion centers. Revenue derived from insurance reimbursements and patient payments for medical infusion services.

prnewswire.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Infusion Associates operates a network of outpatient ambulatory infusion centers that deliver physician-prescribed intravenous infusion therapies to patients with chronic and autoimmune conditions. Services are provided in community-based clinical settings across Michigan, Minnesota, Ohio, and Wisconsin as a convenient, lower-cost alternative to hospital-based infusion care. The company supports referring physicians through streamlined referral processing, in-network insurance coverage, and weekday/weekend scheduling.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Infusion Associates is a single, unified ambulatory infusion services provider. It operates a network of outpatient infusion centers that deliver intravenous therapies and treatments prescribed by physicians. The company focuses on providing convenient, personalized infusion care in a clinic setting as an alternative to hospital-based infusion services.

Product and service1 record
1Ambulatory Infusion Therapy Services
CategoryAmbulatory Infusion Services
Description

Outpatient intravenous infusion therapy delivered to patients with chronic and autoimmune conditions at physician-prescribed doses, administered in community-based clinical settings across Michigan, Minnesota, Ohio, and Wisconsin. Treatments are scheduled with weekday and weekend availability and billed through major commercial insurers, Medicare, Medicare Advantage, and Medicaid. Care is coordinated with the referring physician throughout the treatment course.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-09
Description

Vivo Infusion acquired Infusion Associates on July 9, 2024. This acquisition expanded Vivo Infusion's network to nearly 80 ambulatory infusion centers across 15 states, significantly strengthening its Midwest presence with Infusion Associates' 14 locations in Michigan, Minnesota, Ohio, and Wisconsin.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Infusion Associates

Ambulatory Infusion Servicesinfusionassociates.com

Infusion Associates operates a network of 14 ambulatory infusion centers across Michigan, Minnesota, Ohio, and Wisconsin, providing outpatient IV therapies to chronic disease patients referred by their physicians. The PE-backed company was acquired by Vivo Infusion in July 2024.

What Infusion Associates does

Infusion Associates is an ambulatory infusion services provider headquartered in Grand Rapids, Michigan, that operates outpatient clinical sites delivering intravenous therapies prescribed by physicians for patients with chronic conditions, autoimmune disorders, and other illnesses requiring regular IV administration. The company runs a network of 14 physical infusion centers across Michigan, Minnesota, Ohio, and Wisconsin, positioning itself as a lower-cost, more convenient site of care relative to hospital-based infusion settings. Its value proposition emphasizes community-based access, flexible scheduling including weekends, and in-network status with major commercial payers and government programs (Medicare, Medicare Advantage, Medicaid), reducing patient out-of-pocket cost and supporting referral conversion.

The business operates on a managed-services revenue model, billing through medical codes against insurance reimbursement and patient payments rather than disclosed consumer pricing. Its go-to-market is sales-led and referral-driven: physician practices and healthcare providers are the primary demand channel, with a streamlined referral process, transparent communication back to referring clinicians, and broad payer in-network status serving as the principal commercial assets. Under private equity owner Boyne Capital, the company grew from a single Michigan site to 14 Midwest locations, demonstrating a replicable multi-site expansion playbook. On July 9, 2024, Boyne Capital sold Infusion Associates to Vivo Infusion, which is backed by InTandem Capital Partners and raised nearly $150 million in additional equity during 2024 to continue the roll-up strategy; following the transaction, Infusion Associates operates as part of Vivo's network of approximately 80 ambulatory infusion centers across 15 states. Core technology, proprietary platforms, and AI/ML capabilities are not disclosed in available sources.

Infusion Associates firmographics

Firmographics
Name
Infusion Associates
Legal name
Infusion Associates
Website
https://infusionassociates.com
Company type
Private
Founded year
2004
Operating status
Acquired
Headcount range
101–250 employees
Short description
Infusion Associates operates a network of 14 ambulatory infusion centers across Michigan, Minnesota, Ohio, and Wisconsin, providing outpatient IV therapies to chronic disease patients referred by their physicians. The PE-backed company was acquired by Vivo Infusion in July 2024.
Ownership category
akta.pro rank

Infusion Associates industry classification

Industry
Product category
Ambulatory Infusion Services
NAICS
Outpatient Care Centers (6214), All Other Outpatient Care Centers (621498), Other Outpatient Care Centers (62149)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFABAF
Infusion Therapy Centers (Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Ambulatory infusion services
  • Outpatient infusion therapy
  • Chronic disease infusion
  • IV therapy clinics
  • Infusion care centers

Where Infusion Associates is headquartered

Location

Headquarters

HQ city
Grand Rapids
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Infusion Associates business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Ambulatory Infusion Services: Healthcare services revenue generated from providing infusion therapy treatments to patients at ambulatory infusion centers. Revenue derived from insurance reimbursements and patient payments for medical infusion services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Infusion Associates product offering

Product offering

Core offering

Infusion Associates operates a network of outpatient ambulatory infusion centers that deliver physician-prescribed intravenous infusion therapies to patients with chronic and autoimmune conditions. Services are provided in community-based clinical settings across Michigan, Minnesota, Ohio, and Wisconsin as a convenient, lower-cost alternative to hospital-based infusion care. The company supports referring physicians through streamlined referral processing, in-network insurance coverage, and weekday/weekend scheduling.

Product overview

Infusion Associates is a single, unified ambulatory infusion services provider. It operates a network of outpatient infusion centers that deliver intravenous therapies and treatments prescribed by physicians. The company focuses on providing convenient, personalized infusion care in a clinic setting as an alternative to hospital-based infusion services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ambulatory Infusion Therapy Services Outpatient intravenous infusion therapy delivered to patients with chronic and autoimmune conditions at physician-prescribed doses, administered in community-based clinical settings across Michigan, Minnesota, Ohio, and Wisconsin. Treatments are scheduled with weekday and weekend availability and billed through major commercial insurers, Medicare, Medicare Advantage, and Medicaid. Care is coordinated with the referring physician throughout the treatment course.

Companies that use Infusion Associates

Customer profile

Segments2 records

Ideal customer profiles2 records

Infusion Associates technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Infusion Associates partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Vivo InfusioncoreStrategic or Co-development Partner · 9 July 2024Vivo Infusion acquired Infusion Associates on July 9, 2024. This acquisition expanded Vivo Infusion's network to nearly 80 ambulatory infusion centers across 15 states, significantly strengthening its Midwest presence with Infusion Associates' 14 locations in Michigan, Minnesota, Ohio, and Wisconsin.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Infusion Associates competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Infusion Associates social profiles

Digital presence

Infusion Associates financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Infusion Associates leadership team

Management profile

Number of profiles

Infusion Associates funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Infusion Associates M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Infusion Associates

What does Infusion Associates do?

Infusion Associates operates a network of outpatient ambulatory infusion centers that deliver physician-prescribed intravenous infusion therapies to patients with chronic and autoimmune conditions. Services are provided in community-based clinical settings across Michigan, Minnesota, Ohio, and Wisconsin as a convenient, lower-cost alternative to hospital-based infusion care. The company supports referring physicians through streamlined referral processing, in-network insurance coverage, and weekday/weekend scheduling.

Is Infusion Associates a public or private company?

Infusion Associates is a private company. It is classified as private equity controlled and is currently acquired.

When was Infusion Associates founded?

Infusion Associates was founded in 2004. It employs 101 to 250 people.

Where is Infusion Associates based?

Infusion Associates is headquartered in Grand Rapids, United States, in the North America region.

How does Infusion Associates make money?

One revenue line is on record: ambulatory Infusion Services.

Does Infusion Associates have an API?

No public API is recorded for Infusion Associates.

What industry is Infusion Associates in?

Infusion Associates's product category is Ambulatory Infusion Services. Its primary akta.pro industry code is HLAFABAF, Infusion Therapy Centers (Outpatient), with a secondary code of HLAFALAG, Infusion & Home Infusion Pharmacy Services. Its NAICS code is 6214 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ProvidenthpPrivate Equity Investment in Infusion ServicesProvident Healthcare Partners released a Fall 2024 overview of the infusion services sector, highlighting two significant private equity-backed exits this year: Peak Rock Capital's sale of Paragon Healthcare to Elevance Health and Boyne Capital's sale of Infusion Associates to Vivo Infusion (backed by InTandem Capital). The report estimates the current infusion services market at $120 billion, with hospital settings accounting for 55% of care distribution, followed by physician office infusion centers (30%), home (10%), and ambulatory infusion centers (5%).American City Business JournalsVivo Infusion buys Infusion Associates from Boyne CapitalVivo Infusion acquired Infusion Associates from Boyne Capital, bringing the team into its business. Infusion Associates has 29 employees and over $547 million in pooled capital, and provides ambulatory infusion practices across 14 Midwest locations. The company administers more than 15,000 treatments annually for chronic conditions.BoynecapitalNews – Boyne Capital Announces the Sale of Infusion Associates to Vivo Infusion – Boyne CapitalBoyne Capital sold its portfolio company Infusion Associates to Vivo Infusion. Boyne acquired IA in 2018 and oversaw revenue and EBITDA growth exceeding 5x, expanding from one to 14 locations. The deal is expected to benefit Infusion Associates shareholders.Business Wire BlogVivo Infusion Acquires Infusion AssociatesVivo Infusion acquired Infusion Associates, an ambulatory infusion services provider with centers in Michigan, Minnesota, Ohio, and Wisconsin. The deal expands Vivo's network to nearly 80 centers across 15 states, with financial terms undisclosed. Vivo plans continued growth through additional de novo center build-outs.PR NewswireBoyne Capital Announces the Sale of Infusion Associates to Vivo InfusionBoyne Capital announced the sale of its portfolio company Infusion Associates to Vivo Infusion. Boyne acquired IA in 2018 and oversaw revenue and EBITDA growth exceeding 5x, expanding from one to 14 locations. The company will join the Vivo Infusion platform.YahooVivo Infusion Acquires Infusion AssociatesVivo Infusion acquired Infusion Associates, a Midwest ambulatory infusion provider, expanding its network to nearly 80 centers across 15 states. Financial terms were not disclosed. Vivo plans continued growth through additional de novo center build-outs.VivoinfusionVivo Infusion® Acquires Infusion AssociatesVivo Infusion® announced on July 9, 2024 the acquisition of Infusion Associates, an ambulatory infusion services provider operating centers in Michigan, Minnesota, Ohio, and Wisconsin. Following the transaction, Vivo Infusion® will manage nearly 80 ambulatory infusion centers across 15 states, significantly expanding its Midwest presence. The company's private equity partner, InTandem Capital Partners, raised nearly $150 million in additional equity capital to support continued growth ambitions during 2024 and beyond.PR NewswireInfusion Associates Opens Second Minnesota Location in Woodbury to Treat Patients with Chronic DiseaseInfusion Associates opened its second Minnesota location in Woodbury on May 16, 2024, expanding its outpatient IV therapy services to treat patients with chronic conditions such as multiple sclerosis and Crohn's disease in the Twin Cities area. The new clinic features 10 infusion chairs in both community and private settings, staffed by registered nurses with physician oversight. The company, headquartered in Grand Rapids, Michigan, has been operating for 23 years and now operates locations across Minnesota, Wisconsin, Michigan, and Ohio.PR NewswireInfusion Associates Administers Eisai and Biogen's New Alzheimer's Medication at Their Outpatient Infusion Center in Troy, Mich.Infusion Associates completed its first Leqembi infusion treatment for a patient at their Troy, Michigan outpatient center on October 19, 2023. Leqembi, developed by Eisai and Biogen, is the first disease-modifying treatment for early-stage Alzheimer's disease and mild cognitive impairment to receive full FDA approval, granted on July 6, 2023. The treatment is administered via intravenous infusions every two weeks to patients meeting clinical criteria.PR NewswireFirst Patient in Minnesota Receives TG Therapeutics' New Multiple Sclerosis Drug at Infusion Associates Outpatient Infusion CenterInfusion Associates administered the first dose of TG Therapeutics' Briumvi (ublituximab-xiiy) to a patient in Plymouth, Minnesota. The drug received FDA approval on December 28, 2022, as a disease-modifying therapy for adults with relapsing forms of multiple sclerosis.